Blauvelt A, Leonardi C, Elewski B, Crowley JJ, et al. A Head-to-Head Comparison of Ixekizumab Versus Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis: 24-Week Efficacy and Safety Results from a Randomised, Double-Blinded Trial. Br J Dermatol 2020 Sep 2. doi: 10.1111/bjd.19509.
PMID: 32880909